Bo Ringertz
Impact in
- Geriatrics and Gerontology top 10%
- Pharmaceutical Practices and Patient Outcomes
Papers in
-
- Neutrophil, Myeloperoxidase and Oxidative Mechanisms 6
- Immune Response and Inflammation 5
- Co-authors
- Jan E.W. Palmblad (10 shared papers)Ingiäld Hafström (5 shared papers)Hans Gyllenhammar (7 shared papers)Curt Malmsten (2 shared papers)Olof Rådmark (1 shared paper)Mats Harms‐Ringdahl (1 shared paper)Johan Frostegård (1 shared paper)Lars Lennart Gustafsson (4 shared papers)
- Journals
- Basic & Clinical Pharmacology & Toxicology (2 papers)Arthritis Research & Therapy (1 paper)Inflammation Research (1 paper)Biochimica et Biophysica Acta (BBA) - Bioenergetics (1 paper)Immunology Letters (1 paper)
- Partner nations
- SwedenUnited StatesCanada
In The Last Decade
Bo Ringertz
16 papers receiving 625 citations
Peers
Comparison fields: 5 of 93
- Applied Microbiology and Biotechnology 25
- Geriatrics and Gerontology 39
- Family Practice 11
- Pharmacology 52
- Immunology 125
Countries citing papers authored by Bo Ringertz
This map shows the geographic impact of Bo Ringertz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bo Ringertz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bo Ringertz more than expected).
Fields of papers citing papers by Bo Ringertz
This network shows the impact of papers produced by Bo Ringertz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bo Ringertz. The network helps show where Bo Ringertz may publish in the future.
Co-authors
The 25 scholars most cited alongside Bo Ringertz, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2011 | 206 | |
| 2 | 2008 | 98 | |
| 3 | 1988 | 89 | |
| 4 | 1982 | 78 | |
| 5 | 1987 | 41 | |
| 6 | 1988 | 31 | |
| 7 | 1988 | 27 | |
| 8 | 1991 | 22 | |
| 9 | 2013 | 22 | |
| 10 | 1986 | 11 | |
| 11 | 1984 | 10 | |
| 12 | 1988 | 9 | |
| 13 | [A model for structured introduction of new drugs. The aim is to offer all patients appropriate treatment]. | 2008 | 8 |
| 14 | 1988 | 6 | |
| 15 | 1986 | 5 | |
| 16 | Extraction of Electronic Health Record Data in a Hospital Setting : Comparison of Automatic and Semi-Automatic Methods Using Anti-TNF Therapy as Model | 2012 | 2 |
About Bo Ringertz
Bo Ringertz is a scholar working on Immunology, Neurology, Molecular Biology, Pediatrics, Perinatology and Child Health and Family Practice, having authored 16 papers that have together received 665 indexed citations. Recurring topics across this work include Neutrophil, Myeloperoxidase and Oxidative Mechanisms (6 papers), Immune Response and Inflammation (5 papers), S100 Proteins and Annexins (4 papers), Pharmaceutical studies and practices (2 papers), Cytokine Signaling Pathways and Interactions (2 papers), Blood disorders and treatments (1 paper), Health Systems, Economic Evaluations, Quality of Life (1 paper) and Pharmaceutical industry and healthcare (1 paper). The work is most often cited by research in Applied Microbiology and Biotechnology (25 citations), Geriatrics and Gerontology (39 citations), Family Practice (11 citations), Pharmacology (52 citations) and Immunology (125 citations). Bo Ringertz has collaborated with scholars based in Sweden, United States and Canada. Frequent co-authors include Jan E.W. Palmblad, Ingiäld Hafström, Hans Gyllenhammar, Curt Malmsten, Olof Rådmark, Mats Harms‐Ringdahl, Johan Frostegård, Lars Lennart Gustafsson, Björn Wettermark and Ulf Bergman. Their work appears in journals such as Basic & Clinical Pharmacology & Toxicology, Arthritis Research & Therapy, Inflammation Research, Biochimica et Biophysica Acta (BBA) - Bioenergetics and Immunology Letters.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.